Ftse Mib
33.545,37
0,01%
DAX
18.215,30
0,28%
S&P 500
5.477,90
0,16%
NASDAQ
17.805,16
0,49%
Bitcoin
60.752,45
-0,10%
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Ayala Pharmaceuticals Inc (AYLA) Ayala Pharmaceuticals Inc (AYLA) Notizie

AYLA

Ayala Pharmaceuticals (AYLA)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:AYLA
DataOraFonteTitoloSimboloCompagnia
08/02/202323:17Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:AYLAAyala Pharmaceuticals Inc
06/02/202320:50Edgar (US Regulatory)Schedule 13g
(sc 13g/a)		NASDAQ:AYLAAyala Pharmaceuticals Inc
25/01/202322:54Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AYLAAyala Pharmaceuticals Inc
24/01/202316:22Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AYLAAyala Pharmaceuticals Inc
24/01/202312:07Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:AYLAAyala Pharmaceuticals Inc
19/01/202321:52Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:AYLAAyala Pharmaceuticals Inc
19/01/202321:44Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:AYLAAyala Pharmaceuticals Inc
19/01/202321:33Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:AYLAAyala Pharmaceuticals Inc
04/11/202221:38Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:AYLAAyala Pharmaceuticals Inc
03/11/202221:08Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:AYLAAyala Pharmaceuticals Inc
11/10/202210:46TipRanksH.C. Wainwright Reaffirms Their Buy Rating on Ayala Pharmaceuticals (AYLA)NASDAQ:AYLAAyala Pharmaceuticals Inc
11/10/202210:45TipRanksNoble Financial Reaffirms Their Hold Rating on Ayala Pharmaceuticals (AYLA)NASDAQ:AYLAAyala Pharmaceuticals Inc
27/09/202216:11TipRanksAyala Pharma (NASDAQ:AYLA) Bags fast Track Status for Desmoid Tumor CandidateNASDAQ:AYLAAyala Pharmaceuticals Inc
27/09/202214:58Dow Jones NewsAyala Pharmaceuticals Gets Fast-Track Designation for AL102 Cancer TreatmentNASDAQ:AYLAAyala Pharmaceuticals Inc
19/09/202212:25TipRanksH.C. Wainwright Sticks to Their Buy Rating for Ayala Pharmaceuticals (AYLA)NASDAQ:AYLAAyala Pharmaceuticals Inc
13/09/202214:05TipRanksAyala Pharmaceuticals (AYLA) Receives a Buy from Noble FinancialNASDAQ:AYLAAyala Pharmaceuticals Inc
17/08/202214:05TipRanksNoble Financial Keeps Their Buy Rating on Ayala Pharmaceuticals (AYLA)NASDAQ:AYLAAyala Pharmaceuticals Inc
16/08/202222:40AllPennyStocks.comQ2 Financial Results Send Micro Cap SoaringNASDAQ:AYLAAyala Pharmaceuticals Inc
27/07/202214:25TipRanksNoble Financial Thinks Ayala Pharmaceuticals’ Stock is Going to RecoverNASDAQ:AYLAAyala Pharmaceuticals Inc
26/07/202220:24TipRanksAyala Pharmaceuticals Stock Nearly Triples on Desmoid Tumor Treatment NewsNASDAQ:AYLAAyala Pharmaceuticals Inc
25/07/202223:21Edgar (US Regulatory)Withdrawal of Registration Statement (rw)NASDAQ:AYLAAyala Pharmaceuticals Inc
19/05/202212:26TipRanksH.C. Wainwright Reiterates a Buy Rating on Ayala Pharmaceuticals (AYLA)NASDAQ:AYLAAyala Pharmaceuticals Inc
17/05/202214:45TipRanksNoble Financial Reaffirms Their Buy Rating on Ayala Pharmaceuticals (AYLA)NASDAQ:AYLAAyala Pharmaceuticals Inc
27/04/202222:04Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:AYLAAyala Pharmaceuticals Inc
30/03/202212:35TipRanksAnalysts Conflicted on These Healthcare Names: Acelrx (ACRX) and Ayala Pharmaceuticals (AYLA)NASDAQ:AYLAAyala Pharmaceuticals Inc
28/03/202219:32Edgar (US Regulatory)Annual Report (10-k)NASDAQ:AYLAAyala Pharmaceuticals Inc
09/03/202212:24TipRanksH.C. Wainwright Thinks Ayala Pharmaceuticals’ Stock is Going to RecoverNASDAQ:AYLAAyala Pharmaceuticals Inc
04/02/202215:17Edgar (US Regulatory)Schedule 13gNASDAQ:AYLAAyala Pharmaceuticals Inc
17/01/202223:14TipRanksBuy These 2 Small-Cap Stocks to Double Your Investment, Say AnalystsNASDAQ:AYLAAyala Pharmaceuticals Inc
15/11/202114:00GlobeNewswire Inc.Ayala Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Business UpdateNASDAQ:AYLAAyala Pharmaceuticals Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:AYLA

La tua Cronologia

BIT
P1LU86
BNP Paribas Issuance
TSXV
NEL.UN
Nobel Real Estate Investment
TG
A19HY5
Apple
BOV
BOTZ39R
Global X Funds
AMEX
HDGE
Ranger Equity Bear
NYSE
JW.A
John Wiley and Sons
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network